Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02292550 |
| Title | Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer. |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ITA | FRA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Boston | Massachusetts | 02114 | United States | Details | |
| Novartis Investigative Site | Marseille cedex 05 | 13385 | France | Details | ||
| Novartis Investigative Site | Bologna | BO | 40138 | Italy | Details | |
| Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
| Novartis Investigative Site | Seoul | Seocho Gu | 06591 | Korea, Republic of | Details | |
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
| Novartis Investigative Site | Tainan | Taiwan ROC | 70403 | Taiwan | Details | |
| Novartis Investigative Site | Taipei | 10002 | Taiwan | Details |